ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Survey Finds Misconceptions About Cancer Worldwide

August 29, 2008

Hopkins Challenges Litton For Research Contract At FCRF

April 16, 1982

ACS Modifies Mammography Guidelines

August 5, 1983

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011